Buzzing :

Stock Market LiveStocks to watchN Chandrasekaran ResignsStocks to BuyGold and Silver PriceQ1 Results TodayTATA Group Stocks TodayManappuram Finance ShareGoogle Pixel 11 Series Launch
Home / Company / Quarterly Results / Strides Pharma Science Ltd Quarterly Results

Strides Pharma Science Ltd Quarterly Results

Q1 FY26-27 Results Summary

Revenue

The revenue stands at ₹1,265.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.39 per cent from ₹1,323.47 crore. This corresponds to a year-on-year *(YoY) growth of 13.01 per cent.

Operating Profit

Operating Profit stands at ₹228.49 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.06 per cent from ₹233.30 crore. This corresponds to a year-on-year *(YoY) growth of 8.96 per cent.

PBDT

PBDT stands at ₹256.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.18 per cent from ₹201.30 crore. This corresponds to a year-on-year *(YoY) growth of 49.77 per cent.

Profit Before Tax

Profit Before Tax stands at ₹199.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.83 per cent from ₹148.05 crore. This corresponds to a year-on-year *(YoY) growth of 63.56 per cent.

Net Profit

Net Profit stands at ₹165.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.01 per cent from ₹129.28 crore. This represents a 56.71 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Strides Pharma Science Ltd News

Strides sells majority stake in Pivot Path to Ascent Capital-led consortium

2 min read

Strides Pharma to sell majority stake in Pivot Path for ₹100 crore

2 min read

Strides Pharma Q4FY26 results: Net profit jumps 51% to ₹129 crore

2 min read

Stocks to Watch today: Tata Steel, Tech Mahindra, Varun Bev, Shree Cement

4 min read

Top trading ideas: Buy Thermax, Ipca Labs and one other share, says analyst

4 min read
More

Strides Pharma Science Ltd Earnings

CategoryQ1 FY26-27Q1 FY25-26Change %FY25-26FY24-25Change %
Total Revenue1,265.411,119.7413.014,858.684,565.346.43
Expenses1,036.92910.0313.943,960.233,762.525.25
Other Income68.098.68684.45151.183,313.33-95.44
Operating Profit228.49209.718.961,049.634,116.14-74.50
Depreciation56.4048.8915.36202.40192.265.27
Interest40.5647.46-14.54178.55248.85-28.25
Profit Before Tax199.62122.0563.56668.693,675.03-81.80
Tax34.1316.45107.4877.8846.9166.02
Net Profit165.49105.6056.71574.523,597.51-84.03
CategoryQ1 FY26-27Q4 FY25-26Change %
Total Revenue1,265.411,323.47-4.39
Expenses1,036.921,090.17-4.88
Other Income68.099.58610.75
Operating Profit228.49233.30-2.06
Depreciation56.4053.255.92
Interest40.5641.58-2.45
Profit Before Tax199.62148.0534.83
Tax34.1318.7781.83
Net Profit165.49129.2828.01

Strides Pharma Science Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Strides Pharma Science Ltd Financial Reports

Data not available.

Strides Pharma Science Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Strides Pharma0.10%0.99%-6.45%-12.28%17.28%15.51%
Sanofi Consumer-1.01%-1.18%-1.42%-2.09%4.76%-11.59%
Orchid Pharma-1.43%6.10%5.18%52.43%59.46%38.02%
P & G Health Ltd-0.73%-1.43%-12.58%14.91%20.61%-2.91%
Aarti Pharma3.22%31.95%26.86%28.84%28.52%15.20%
Sanofi India-1.21%-2.72%-2.48%0.39%-19.37%-35.61%
Senores Pharma.0.77%10.82%2.68%50.68%87.49%116.26%

Strides Pharma Science Ltd Corporate Information

Chairman & Non Executive Dir.: Arun Kumar
Group CEO & Executive Director: Badree Komandur
Executive Director & COO: VENKATA SEETHARAMA RAJU PAKALAPATI
Independent Non Exe. Director: Kausalya Santhanam
Independent Non Exe. Director: Mukta Malik Arora
Independent Non Exe. Director: Subir Chakraborty
Independent Non Exe. Director: Homi R Khusrokhan
Independent Non Exe. Director: Ameet Hariani
Company Sec. & Compli. Officer: Manjula Ramamurthy

Strides Pharma Science Ltd News

No More Data

More